Do Billionaires Already Have Anti-Ageing Treatments? Here’s What We Know
Wealth can buy exceptional healthcare and early access to research, but does it buy a proven way to slow human ageing? Dr Deepa examines the evidence behind the headlines.
Wealth can buy exceptional healthcare and early access to research, but does it buy a proven way to slow human ageing? Dr Deepa examines the evidence behind the headlines.
Several biotechnology companies are now testing ambitious anti-aging approaches. But entering human trials is not the same as reversing aging. Here is what to look for when judging the evidence.
A new human trial has begun testing genetic instructions intended to make older cells behave more like younger ones. But what was injected, what is being tested, and what has not yet been shown?
Off-label prescribing is common, but it deserves careful questions after 60. Learn why a medicine’s approved label is only part of the story—and what makes prescribing safer.
Magnesium matters, but increasing a supplement dose after 60 is not always straightforward. Kidney function, medicines, blood pressure, total intake and symptoms can all change the picture.
A standard cholesterol panel is valuable, but it may not include Lp(a), an inherited risk marker that can add important context to your heart-health picture.
After 60, everyday challenges such as stairs, poor sleep or a minor illness can sometimes have a bigger effect. Learn why shrinking reserves may matter more than any single test result.
Five simple movement and recovery checks can offer a useful snapshot of physical reserve after 60. Learn what they may reveal—and why one result should never be treated as a prediction.
Blood tests matter, but they do not show how well you move, recover, or stay steady. Two simple checks may offer useful clues about physical reserve after 60.
A normal blood pressure or cholesterol result can be reassuring after 60, but it may not tell the whole story. Learn the questions that can reveal a more complete picture of heart risk.